Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
AstraZeneca
Harvard Business School
Boehringer Ingelheim
Colorcon

Last Updated: May 28, 2022

CLINICAL TRIALS PROFILE FOR LYMPHOSEEK KIT


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Lymphoseek Kit

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00671918 ↗ Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma Completed Navidea Biopharmaceuticals Phase 3 2008-04-01 Data from this pivotal clinical trial will be used to support a marketing application (i.e., NDA) for Navidea's Lymphoseek for use in intraoperative localization of lymph tissue (nodes) in the lymphatic pathway draining the primary site of a tumor.
NCT00911326 ↗ Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma Terminated Navidea Biopharmaceuticals Phase 3 2009-05-01 The purpose of this study is to determine the false negative rate (FNR) associated with Lymphoseek-identified sentinel lymph nodes (SLNs) relative to the pathological status of non-sentinel lymph nodes in elective neck dissection (END) in head & neck squamous cell carcinoma (HNSCC). NEO3-06 (this study) is a Phase 3 clinical trial designed to supplement NEO3-05, a completed Phase 3 clinical trial conducted in patients with breast cancer or melanoma. NEO3-05 was designed to establish Lymphoseek as an effective radio-diagnostic agent to be used in the intraoperative localization of lymph tissue (nodes) in the lymphatic pathway draining the primary site of a tumor.
NCT01106040 ↗ Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes Completed Navidea Biopharmaceuticals Phase 3 2010-06-01 Data from this pivotal clinical trial will be used to support a marketing application (i.e., NDA) of Navidea's Lymphoseek for use in anatomical delineation of lymphoid tissue (nodes) in the lymphatic pathway draining the primary site of a tumor. Multicenter, open-label, within-patient comparative study of Lymphoseek and vital blue dye in the detection of excised lymph nodes in patients with known melanoma and breast cancer. All patients will receive a single dose of 50 µg Lymphoseek radiolabeled with 0.5 or 2.0 mCi Tc 99m and vital blue dye.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lymphoseek Kit

Condition Name

Condition Name for Lymphoseek Kit
Intervention Trials
Melanoma 5
Rheumatoid Arthritis 5
Breast Cancer 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Lymphoseek Kit
Intervention Trials
Arthritis 5
Melanoma 5
Breast Neoplasms 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Lymphoseek Kit

Trials by Country

Trials by Country for Lymphoseek Kit
Location Trials
United States 55
Switzerland 1
Israel 1
Spain 1
United Kingdom 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Lymphoseek Kit
Location Trials
California 13
Ohio 8
Florida 7
Pennsylvania 5
Alabama 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Lymphoseek Kit

Clinical Trial Phase

Clinical Trial Phase for Lymphoseek Kit
Clinical Trial Phase Trials
Phase 4 2
Phase 3 4
Phase 2 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Lymphoseek Kit
Clinical Trial Phase Trials
Completed 11
Terminated 4
Recruiting 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Lymphoseek Kit

Sponsor Name

Sponsor Name for Lymphoseek Kit
Sponsor Trials
Navidea Biopharmaceuticals 17
Cardinal Health 414, LLC 4
National Cancer Institute (NCI) 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Lymphoseek Kit
Sponsor Trials
Industry 21
Other 10
NIH 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Mallinckrodt
Merck
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.